KNTE

Kinnate Biopharma Inc. Common Stock

Delisted

KNTE was delisted on the 2nd of April, 2024.

71 hedge funds and large institutions have $270M invested in Kinnate Biopharma Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
71
Holders Change
-8
Holders Change %
-10.13%
% of All Funds
1.14%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
6
Increased
24
Reduced
22
Closed
14
Calls
$277K
Puts
$74K
Net Calls
+$203K
Net Calls Change
+$203K
Name Holding Trade Value Shares
Change
Shares
Change %
Squarepoint
76
Squarepoint
New York
-$153K -25,091 Closed
CSS
77
Cubist Systematic Strategies
Connecticut
-$112K -18,386 Closed
JF
78
Jump Financial
Illinois
-$92.1K -15,100 Closed
Marshall Wace
79
Marshall Wace
United Kingdom
-$91.2K -14,944 Closed
PMEF
80
Point72 Middle East FZE
United Arab Emirates
-$10.2K -1,675 Closed
Russell Investments Group
81
Russell Investments Group
United Kingdom
-$5.83K -955 Closed
S
82
SignatureFD
Georgia
-$726 -119 Closed
US Bancorp
83
US Bancorp
Minnesota
-$689 -113 Closed
Federated Hermes
84
Federated Hermes
Pennsylvania
-$24 -4 Closed
CS
85
Credit Suisse
Switzerland
-$6 -1 Closed